Saudi Arabia: Clinics, Agencies, Contracts and Payments — Permitted Activities and Risks
The short answer
The central legal line is clinical, not commercial. Article 5 of Saudi Arabia’s Law of Fertilization, Utero-Fetal and Infertility Treatment Units prohibits implanting a fertilized egg from a married couple into the womb of another wife or another woman. A clinic, agency, contract, consent form or payment schedule cannot make that prohibited transfer permissible. A programme built around gestational surrogacy in Saudi Arabia should therefore be treated as a stop-and-review issue, not as an ordinary service purchase.
This does not mean that every infertility treatment or every intermediary fee is automatically unlawful. Saudi law permits certain infertility treatments within statutory conditions and licensed facilities. The task is to separate those permitted services from the prohibited embryo transfer, and not to rely on labels, marketing claims or a signed agreement as proof of legality.
Scope and strength of the evidence
This guide reflects official Saudi legal texts published by the Bureau of Experts at the Council of Ministers, as of 23 October 2026. The official database marks the fertilization-unit law and the Civil Transactions Law as in force. The specialized law also requires fertility and embryo units to comply with fatwas issued by the Council of Senior Ulama (Article 3).
The Ministry of Health hosts an English PDF containing the law and implementing regulations. It includes requirements for eligibility for infertility treatment and a narrow qualification to the post-death treatment rule, but the document’s current amendment status and application to a live case were not independently confirmed. No claim is made that the sources cover every rule that could apply. The contract analysis below applies general statutory wording to a proposed surrogacy arrangement; it is not a claim that a reported Saudi judgment on an identical contract was located.
The prohibited clinical step
Article 5 expressly says that a fertilized egg from a married couple may not be implanted in the womb of another wife or another woman. That wording reaches the core clinical step of gestational surrogacy when an embryo created for one couple is transferred to a different woman to carry the pregnancy. The rule is not framed as a ban only on commercial arrangements: Article 5 contains no express exception for an unpaid, altruistic, family or relative-based arrangement.
The statutory text also prohibits insemination with sperm from someone other than the husband and fertilization of an egg belonging to someone other than the wife. A programme cannot avoid these restrictions simply by describing the payment as a medical fee, an agency fee, reimbursement or a donation. The legal question is what procedure and purpose the arrangement actually involves, including what the documents and surrounding circumstances show.
Infertility treatment that may be provided within the law
The specialized law regulates infertility treatment; it does not give blanket approval to every assisted-reproduction method. Article 2 permits medical intervention for infertility resulting from reduced fertility or a treatable medical condition, supported by a medical report; fertilization procedures must not be used to treat infertility classified as incurable under the law. The Ministry of Health-hosted implementing-regulations text requires a report from a licensed unit or centre confirming the diagnosis, ability to procreate and permissibility of treatment. Because this classification is medically specific, eligibility for an individual patient must be confirmed against the current rules and clinical record.
Article 4 requires proof of an existing marriage before treatment begins. The published implementing regulations say that if the husband dies, the physician must stop the process and refrain from implanting the fertilized egg or transferring sperm to the wife’s uterus unless a written fatwa from the Council of Senior Ulama exists; after divorce or a dispute between the spouses, treatment must stop. This is a narrow qualification of the post-death rule for treatment involving the wife; it does not create an exception to Article 5’s separate prohibition on implanting an embryo in another woman. Article 6 requires the spouses’ explicit written consent to the chosen treatment after they have been informed of the procedures, risks and possible outcomes. Article 7 requires at least two specialists to verify both spouses’ identities and medical-record numbers at sample collection, fertilization and embryo transfer. Article 9 requires careful control and traceability of sperm, eggs, fertilized eggs and embryos to prevent mixing or substitution.
These are conditions on lawful treatment, not a route to surrogacy. In particular, consent by the intended parents or the woman carrying a pregnancy does not override Article 5’s prohibition on transfer to another woman.
Clinic licensing and treatment levels
Under Article 19, a fertilization, embryo and infertility-treatment unit may not be established or operated without a Ministry of Health licence based on a recommendation from the supervisory committee. Article 20 divides licensed activity into levels: Level 1 covers infertility treatment with ovulation-inducing medicines by injection; Level 2 covers artificial insemination; and Level 3 covers in-vitro fertilization, intracytoplasmic sperm injection and micromanipulation, subject to the implementing rules.
The general Law of Private Health Institutions and the Law of Practicing Healthcare Professions add licensing requirements for health facilities and individual practitioners. A commercial registration, a general clinic licence, a website, a referral from an agent or a photograph of a certificate is not proof that the specific fertility unit and procedure are licensed. Ask the competent authority to confirm the current facility licence, treatment level, responsible clinician and any limits that apply.
Penalties and who may be exposed
Article 32 provides that one or more of the following sanctions may apply to a person who commits one of its listed violations: a fine of SAR 200,000 to SAR 500,000, imprisonment for up to five years, or cancellation of the professional-practice licence. The listed violations include operating without a licence or above the licensed level; injecting sperm or embryos from someone other than the husband; performing fertilization after the marital relationship has ended; transferring embryos belonging to one woman into another woman’s womb; and deceiving or exploiting a patient or using unsound medical methods for extortion or exploitation.
For other violations of the law or its implementing rules, Article 33 provides for one or more sanctions including a warning, a fine of SAR 20,000 to SAR 200,000, imprisonment for up to two years, or cancellation of the professional-practice licence. These provisions do not mean that every sanction automatically applies in every case, or that every intended parent, payer or agency faces the same offence. The specific act, the person’s role, any other applicable law and the competent proceedings must be assessed.
Can a surrogacy contract be enforced?
The Civil Transactions Law supplies a separate contract-law risk. Article 72 requires the subject of an obligation to be possible, not contrary to public order, and sufficiently identified or identifiable; a contract fails if those conditions are not met. Article 75 states that a contract is void when the motive prompting the parties to contract is unlawful, if that motive is stated in the contract or can be inferred from the circumstances. Articles 74 and 84 contain related but distinct severability rules: Article 74 addresses an invalid contractual condition, while Article 84 addresses a contract that is void or may be nullified in part. Ordinarily the defect is limited to the affected part, but a party may seek nullity of the whole contract if it would not have agreed without that part.
Applied to a contract whose central promise is to arrange an embryo transfer prohibited by Article 5, these provisions create a substantial risk that the central obligation, and potentially the agreement as a whole, will be treated as void or unenforceable. This is a statutory analysis, not a reported court ruling on a specific contract. The outcome may depend on the exact wording, actual purpose, parties, services already performed and whether any lawful services are genuinely separable.
A signature, notarization, translation, private consent, payment receipt or choice-of-law clause cannot by itself override the Saudi statutory restriction. A separate contract for lawful medical consultation, translation or unrelated travel services needs its own analysis; do not assume it is automatically void, and do not assume it protects a prohibited core arrangement.
Articles 81 and 82 address consequences of nullity: an interested person may invoke it and a court may raise it on its own; ratification does not cure nullity. The law provides for the parties to be restored to their pre-contract position, and compensation may be ordered if restoration is impossible. Article 81 also contains a ten-year rule for hearing a nullity action, while a defence based on nullity may be raised at any time. A Saudi lawyer should assess how these rules apply to the specific claim and any transitional or procedural issues.
Agencies, brokers and referral commissions
The reviewed fertility law regulates clinical units, treatment methods and specified violations. The sources do not establish a separate blanket offence merely because a business calls itself a “surrogacy agency”. That is not approval of the agency’s promised service. If an agency’s central contractual promise is to secure a prohibited embryo transfer, the contract-object and unlawful-motive rules may be engaged; any separate criminal or administrative liability requires analysis of the actual conduct and other applicable rules.
The Law of Practicing Healthcare Professions, Article 12, prohibits a healthcare practitioner from requesting, accepting or taking a commission or benefit in return for promoting or referring patients to a particular pharmacy, hospital, laboratory or similar provider. This rule concerns healthcare practitioners; it should not be misstated as a blanket ban on every independent agency service fee. Ask the agency to identify its legal entity, exact work, subcontractors, payment recipients and any referral commissions, and ask the clinic to disclose any financial relationship with the intermediary.
Payments, cancellation and refunds
No official Saudi tariff or special statutory surrogacy-refund schedule was identified in the sources. Do not invent a standard price, assume an advertised package is approved, or treat payment as proof that the service is lawful. If the main purpose of the agreement is prohibited, a refund clause cannot legalize it and a non-refundable label does not by itself settle the legal result.
The Civil Transactions Law’s nullity rules contemplate restoration to the position before contracting, but that does not guarantee recovery of every amount paid. A dispute may turn on the payment recipient, the contract’s actual purpose, evidence of performance, any lawful and separable services, and the court’s treatment of restitution or compensation. Keep a clear distinction between money paid for lawful medical care actually supplied and money paid to arrange the prohibited clinical step.
Before any lawful fertility-treatment payment, request an itemized estimate, the exact legal name of the payee, a tax or payment receipt where applicable, a written schedule tied to defined services, and cancellation terms covering medical contraindications, clinic refusal, unused medicines, storage charges and unperformed services. Prefer traceable payments to the contracting entity. These are risk-control recommendations, not a claim that Saudi law mandates a particular escrow system or refund percentage.
Due-diligence checklist before signing or paying
Use the following checklist for lawful infertility treatment or for reviewing an intermediary proposal. A “yes” answer does not authorize surrogacy; any plan involving transfer of an embryo into another woman’s womb should be stopped and reviewed by independent Saudi counsel.
| Check | What to obtain or confirm | Why it matters |
|---|---|---|
| Clinic and clinician | Current Ministry of Health licence, fertility-unit level, responsible clinician’s professional licence and written confirmation of the proposed method. | General marketing or business registration does not establish authority to perform the specific procedure. |
| Procedure and participants | A written treatment plan identifying whose sperm and egg will be used, where an embryo will be transferred and which facility will perform each step. | A transfer to another woman’s womb and third-party gametes raise direct Article 5 issues. |
| Consent and records | Explicit written consent from the spouses after disclosure of procedures, risks and possible outcomes; records identifying samples and embryos. | Articles 6, 7 and 9 set consent, identity-checking and handling requirements. |
| Agency role | Exact legal entity, deliverables, subcontractors, commission basis, referral relationships and the party responsible for each service. | It helps distinguish a lawful administrative service from a promise to arrange a prohibited clinical act or a potentially improper practitioner referral payment. |
| Price and refund | Itemized fee schedule, named payee, receipts, payment milestones, cancellation events, unused balances and refund-dispute process. | It creates evidence and reduces uncertainty; it does not make a prohibited service lawful. |
| Disputes and governing law | Written complaint route, dispute forum, governing-law wording and a copy of every version signed. | A dispute clause does not cure an unlawful subject or motive; enforceability needs specific advice. |
Warning signs that require a pause
Pause before paying if a clinic will not show its current fertility-unit licence or treatment level; the agency will not name the clinic or the actual service provider; the contract hides embryo transfer under vague terms such as “coordination” or “family-building package”; or the parties are asked to describe a surrogacy payment as an unrelated medical fee, donation or reimbursement. Concealing the real purpose can make the circumstances relevant to the Civil Transactions Law’s unlawful-motive test.
Other red flags include promises of a guaranteed baby, parentage, citizenship or exit documents; payment to a personal account unrelated to the contract; unexplained cash demands; no receipts or refund terms; pressure to sign immediately; refusal to provide informed consent documents; use of third-party gametes; or a practitioner receiving an undisclosed benefit for a referral. These signs do not themselves prove a crime, but they justify stopping the transaction and obtaining independent advice.
If you have already signed or paid
Do not make another payment simply to protect a deposit or because an intermediary says the next instalment is irreversible. First obtain copies of the signed contract and every amendment, invoices, receipts, bank records, advertisements, messages, the treatment plan, consent forms and any licence documents. Preserve original files and dates; do not backdate documents, sign a false description of the service or delete communications.
Ask the contracting party in writing for an itemized account of sums received, services actually performed, unused funds, the contractual basis for any deduction and its proposed refund position. Avoid threats or public accusations. Have a Saudi lawyer review whether the central agreement may be void, whether lawful services are severable, who has standing to claim, what evidence is needed, the appropriate forum and any time limits. A possible nullity or restitution argument is not a guaranteed refund.
If the concern is a clinic’s licence, treatment level, consent practice or handling of samples, verify the current complaint route with the Saudi Ministry of Health or other competent authority and submit factual supporting records. Do not assume that a general commercial complaint alone will resolve a specialist healthcare-licensing issue.
Cross-border arrangements and the safest next step
A foreign agency, foreign clinic, overseas payment account or contract governed by another country’s law does not answer whether conduct in Saudi Arabia is permitted, whether a Saudi-facing contract is enforceable, or how a foreign judgment or parentage record will be treated. Conversely, this article does not decide the legality of a procedure performed entirely abroad. The place of the medical acts, the parties, the payment flow, the contract terms and the forum must be assessed separately; do not assume that foreign legality settles Saudi consequences or that Saudi rules automatically decide every foreign issue.
Before proceeding, obtain independent written Saudi legal advice on the proposed clinical steps and contracts, and separate that advice from any advice on the law of the country where a procedure might occur. Ask for official confirmation of licences and a medically accurate treatment plan. Do not pay for a prohibited embryo transfer or rely on promises about parentage, citizenship, birth registration or travel; those are separate legal questions requiring their own analysis.
The practical bottom line is narrow but important: Saudi law expressly prohibits transferring a fertilized egg from a married couple to another woman’s womb. Lawful infertility treatment, clinic authority, agency services, contract enforceability and recovery of payments are distinct questions.
Sources and legal texts
The Bureau of Experts database texts are in Arabic; the Ministry of Health PDF is in English, but its current amendment status has not been independently confirmed. Source titles below are descriptive and do not replace the controlling legal texts.
- Law of Fertilization, Utero-Fetal and Infertility Treatment Units (Royal Decree M/76; current status shown as active) (S1)
- Civil Transactions Law (Royal Decree M/191; current status shown as active) (S2)
- Law of Private Health Institutions (Royal Decree M/40; current status shown as active) (S3)
- Law of Practicing Healthcare Professions (Royal Decree M/59; current status shown as active) (S4)
- Ministry of Health: English PDF of the law and implementing regulations (current amendment status not confirmed) (S5)
